+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Contrave"

Anti-Obesity Drugs Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Mechanism of Action, Type of Agonist, Action Pathway, Route of Administration, Geographical Regions, Sales Forecast and Key Players - Product Thumbnail Image

Anti-Obesity Drugs Market Industry Trends and Global Forecasts to 2035, by Type of Molecule, Active Compound Used, Mechanism of Action, Type of Agonist, Action Pathway, Route of Administration, Geographical Regions, Sales Forecast and Key Players

  • Report
  • January 2025
  • 240 Pages
  • Global
From
Anti-obesity Medication Market - Product Thumbnail Image

Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Anti-obesity Medication Market Size, Share & Trends Analysis Report by Product (Approved, Off-label), Mechanism Of Action (Peripherally Acting Drugs, Centrally Acting Drugs), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 110 Pages
  • Global
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Wegovy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Global
From
Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 342 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Contrave is a prescription anti-obesity drug that combines two medications, naltrexone and bupropion, to help people lose weight. It is used in combination with a reduced-calorie diet and exercise program to help people lose weight and keep it off. Contrave works by decreasing appetite and increasing feelings of fullness. It also helps to reduce cravings for food and alcohol. Contrave is one of several anti-obesity drugs available on the market. Other drugs include orlistat, lorcaserin, and phentermine/topiramate. These drugs are used to help people lose weight and reduce the risk of obesity-related health problems. Companies in the Contrave market include Orexigen Therapeutics, Takeda Pharmaceuticals, and Eisai Co. Ltd. Show Less Read more